ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer

Han, Xiaoyu; Wang, Mingliang; Zheng, Yuting; Wang, Na; Wu, Ying; Ding, Chengyu; Jia, Xi; Yang, Ran; Geng, Mingfei; Chen, Zhen; Zhang, Songlin; Zhang, Kailu; Li, Yumin; Liu, Jia; Gu, Jin; Liao, Yongde*; Fan, Jun*; Shi, Heshui*华中科技大学; 郑州大学; 1
European Radiology2023-9-22DOI: 10.1007/s00330-023-10241-x
9阅读
引用收藏
分享

摘要

ObjectivesTo investigate if delta-radiomics features have the potential to predict the major pathological response (MPR) to neoadjuvant chemoimmunotherapy in non-small cell lung cancer (NSCLC) patients.MethodsTwo hundred six stage IIA-IIIB NSCLC patients from three institutions (Database1 = 164; Database2 = 21; Database3 = 21) who received neoadjuvant chemoimmunotherapy and surgery were included. Patients in Database1 were randomly assigned to the training dataset and test dataset, with a ratio of 0.7:0.3. Patients in Database2 and Database3 were used as two independent external validation datasets. Contrast-enhanced CT scans were obtained at baseline and before surgery. The delta-radiomics features were defined as the relative net change of radiomics features between baseline and preoperative. The delta-radiomics model and pre-treatment radiomics model were established. The performance of Immune-Related Response Evaluation Criteria in Solid Tumors (iRECIST) for predicting MPR was also evaluated.ResultsHalf of the patients (106/206, 51.5%) showed MPR after neoadjuvant chemoimmunotherapy. For predicting MPR, the delta-radiomics model achieved a satisfying area under the curves (AUCs) values of 0.768, 0.732, 0.833, and 0.716 in the training, test, and two external validation databases, respectively, which showed a superior predictive performance than the pre-treatment radiomics model (0.644, 0.616, 0.475, and 0.608). Compared with iRECIST criteria (0.624, 0.572, 0.650, and 0.466), a mixed model that combines delta-radiomics features and iRECIST had higher AUC values for MPR prediction of 0.777, 0.761, 0.850, and 0.670 in four sets.ConclusionThe delta-radiomics model demonstrated superior diagnostic performance compared to pre-treatment radiomics model and iRECIST criteria in predicting MPR preoperatively in neoadjuvant chemoimmunotherapy for stage II-III NSCLC.Clinical relevance statementDelta-radiomics features based on the relative net change of radiomics features between baseline and preoperative CT scans serve a vital support tool in accurately identifying responses to neoadjuvant chemoimmunotherapy, which can help physicians make more appropriate treatment decisions.Key Points & BULL; The performances of pre-treatment radiomics model and iRECIST model in predicting major pathological response of neoadjuvant chemoimmunotherapy were unsatisfactory.& BULL; The delta-radiomics features based on relative net change of radiomics features between baseline and preoperative CT scans may be used as a noninvasive biomarker for predicting major pathological response of neoadjuvant chemoimmunotherapy.& BULL; Combining delta-radiomics features and iRECIST can further improve the predictive performance of responses to neoadjuvant chemoimmunotherapy.Key Points & BULL; The performances of pre-treatment radiomics model and iRECIST model in predicting major pathological response of neoadjuvant chemoimmunotherapy were unsatisfactory.& BULL; The delta-radiomics features based on relative net change of radiomics features between baseline and preoperative CT scans may be used as a noninvasive biomarker for predicting major pathological response of neoadjuvant chemoimmunotherapy.& BULL; Combining delta-radiomics features and iRECIST can further improve the predictive performance of responses to neoadjuvant chemoimmunotherapy.Key Points & BULL; The performances of pre-treatment radiomics model and iRECIST model in predicting major pathological response of neoadjuvant chemoimmunotherapy were unsatisfactory. @@@ & BULL; The delta-radiomics features based on relative net change of radiomics features between baseline and preoperative CT scans may be used as a noninvasive biomarker for predicting major pathological response of neoadjuvant chemoimmunotherapy.& BULL; Combining delta-radiomics features and iRECIST can further improve the predictive performance of responses to neoadjuvant chemoimmunotherapy.

学科与关键词

关键词
HumansCarcinoma, non-small-cell lungNeoadjuvant therapyArea under the curveResponse Evaluation Criteria in Solid Tumors
相关
加载中…
  • Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
    Tankyevych, Olena; Trousset, Flora; Latappy, Claire; Berraho, Moran; Dutilh, Julien; Tasu, Jean Pierre; Lamour, Corinne; Cheze Le Rest, CatherineCancers, 2022, 14(23): 5931.被引 10
  • Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective study
    Wu, Shaowei; Zhan, Weijie; Liu, Lan; Xie, Daipeng; Yao, Lintong; Yao, Henian; Liao, Guoqing; Huang, Luyu; Zhou, Yubo; You, Peimeng; Huang, Zekai; Li, Qiaxuan; Xu, Bin; Wang, Siyun; Wang, Guangyi; Zhang, Dong-Kun; Qiao, Guibin; Chan, Lawrence Wing-Chi; Lanuti, Michael; Zhou, Haiyu*Journal for ImmunoTherapy of Cancer, 2023, 11(10): e007369.
  • Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast Cancer
    Zeng, Qiao; Xiong, Fei; Liu, Lan; Zhong, Linhua; Cai, Fengqin; Zeng, Xianjun*ACADEMIC RADIOLOGY, 2023, 30 Suppl 2: S38-S49.
查看全部 →

发表信息

论文状态
公开发表
期刊
European Radiology
发表日期
2023-09-22
DOI
10.1007/s00330-023-10241-x
语言
ENGLISH
成果收录
SCIE
资助标注
HSS, JF, and YDL did the conception and design of the study and the acquisition of data. XYH, YW, CYD, JL, XJ, KLZ, YML, JL, RY, ZC, and JG did analysis and interpretation of the data. XYH and MLW draft the article. All authors did final approval of the ve

作者

  • H

    Han, Xiaoyu (第一作者)

    huazhong univ sci & technol

  • W

    Wang, Mingliang

    henan prov peoples hosp · zhengzhou univ · huazhong univ sci & technol

查看全部 18 位作者收起作者
  • Z

    Zheng, Yuting

    huazhong univ sci & technol

  • W

    Wang, Na

    huazhong univ sci & technol

  • W

    Wu, Ying

    huazhong univ sci & technol

  • D

    Ding, Chengyu

  • J

    Jia, Xi

    huazhong univ sci & technol

  • Y

    Yang, Ran

    henan univ

  • G

    Geng, Mingfei

    henan univ

  • C

    Chen, Zhen

    1 · china three gorges univ

  • Z

    Zhang, Songlin

    1 · china three gorges univ

  • Z

    Zhang, Kailu

    huazhong univ sci & technol

  • L

    Li, Yumin

    huazhong univ sci & technol

  • L

    Liu, Jia

    huazhong univ sci & technol

  • G

    Gu, Jin

    huazhong univ sci & technol

  • L

    Liao, Yongde (通讯)

    huazhong univ sci & technol

  • F

    Fan, Jun (通讯)

    1 · china three gorges univ

  • S

    Shi, Heshui (通讯)

    huazhong univ sci & technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417